So, we're off on Roche talking about their new CGM. How close were Diabettech's predictions?
#ATTD2024
via @diabettechdiabettech.com/cgm/a-new-cgm-…
Lots of focus on sleep and Hypos in @drpratikc 's presentation. Wonder why? 🤔
@drpratikc Where might this go next?
#ATTD2024
@drpratikc Features of the new potential product that's not finalised and not CE Marked....
We got the name right ...
#ATTD2024
#Roche
@drpratikc Two apps. One a reader and one predictive.
Needs initial calibration.
But two apps? Really? I hope they explain that.
#ATTD2024
@drpratikc Small study size (on a par with some of the Chinese sensors I've looked at and 83% type 1.
MARD around 9.2%, consensus error grid results look good.
#ATTD2024
@drpratikc Looks a lot like a Libre, but with a flat bit, because Abbott have a patent on round sensors... 🤔
#ATTD2024
@drpratikc With Glucose prediction out to two hours... As discussed in Diabettech.
Perhaps more interesting is the personalised nighttime predictions using AI.
#ATTD2024
@drpratikc And this is how the data is presented. Because it is predicted, there's a set of error bars to take that into account.
#ATTD2024
@drpratikc The alerts within 30 mins don't seem that different from other systems.
The nighttime is very different though. No-one is doing this right now.
#ATTD2024
It uses time based data to some extent to determine outcomes, so yesterday night is included, but also uses the CGM data to identify meals, exercise and estimate insulin to figure out hypo risk.
#ATTD2024
Rumour in the hall that we'll see a CE mark in June!
#ATTD2024
@threadreaderapp unroll
Share this Scrolly Tale with your friends.
A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.